Bristol Myers Squibb (BMY) Debt Ratio (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Debt Ratio data on file, last reported at 0.51 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.51, down 4.41% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.51 (down 4.41% YoY), and the FY2025 annual result was 0.5, down 6.55% from the prior year.
• Debt Ratio grew to 0.51 in Q1 2026 per BMY's latest filing, from 0.5 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.56 in Q1 2024 and troughed at 0.4 in Q3 2022.
• A 5-year average of 0.47 and a median of 0.5 in 2025 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio declined 8.07% in 2023, then soared 40.12% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.41 in 2022, then increased by 2.92% to 0.42 in 2023, then gained by 28.28% to 0.54 in 2024, then dropped by 6.55% to 0.5 in 2025, then climbed by 2.62% to 0.51 in 2026.
• Business Quant data shows BMY's Debt Ratio at 0.51 in Q1 2026, 0.5 in Q4 2025, and 0.51 in Q3 2025.